Thinking epilepsy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:166424G40.5
Who is this for?
Show terms as
2Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thinking epilepsy, also known as cognitive-triggered epilepsy or noogenic epilepsy, is a rare form of reflex epilepsy in which seizures are specifically provoked by higher cognitive activities such as mental calculation, decision-making, spatial reasoning, or other complex thought processes. It is classified under special epileptic syndromes (ICD-10: G40.5). The condition primarily affects the central nervous system, with seizures believed to originate from or involve frontal and parietal cortical networks engaged during cognitive tasks. Seizures are most commonly generalized, often presenting as myoclonic jerks, absence seizures, or generalized tonic-clonic seizures triggered by specific mental efforts. The onset of thinking epilepsy is typically in adolescence or young adulthood. Patients may notice that activities such as performing arithmetic, playing strategy games (e.g., chess), solving puzzles, or making complex decisions reliably provoke seizures. Electroencephalography (EEG) during cognitive tasks typically shows generalized spike-and-wave or polyspike-and-wave discharges. The condition may overlap with or occur in the context of idiopathic generalized epilepsy syndromes, particularly juvenile myoclonic epilepsy, where cognitive triggers can be an additional precipitating factor. Treatment involves avoidance of known cognitive triggers where feasible, though this is often impractical. Antiseizure medications are the mainstay of management, with valproic acid being the most commonly used and generally effective drug. Levetiracetam and lamotrigine may also be considered. Prognosis is generally favorable with appropriate medication, though seizures may recur if triggers cannot be avoided and medication is discontinued. Patients benefit from education about their specific triggers and strategies to manage cognitive load.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Juvenile

Begins in the teen years

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Thinking epilepsy.

View clinical trials →

No actively recruiting trials found for Thinking epilepsy at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Thinking epilepsy community →

Specialists

2 foundView all specialists →
MW
Mary Ann Werz
Specialist
PI on 1 active trial
TS
Tanya Spruill
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Thinking epilepsy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Thinking epilepsyForum →

No community posts yet. Be the first to share your experience with Thinking epilepsy.

Start the conversation →

Latest news about Thinking epilepsy

No recent news articles for Thinking epilepsy.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Thinking epilepsy

What is Thinking epilepsy?

Thinking epilepsy, also known as cognitive-triggered epilepsy or noogenic epilepsy, is a rare form of reflex epilepsy in which seizures are specifically provoked by higher cognitive activities such as mental calculation, decision-making, spatial reasoning, or other complex thought processes. It is classified under special epileptic syndromes (ICD-10: G40.5). The condition primarily affects the central nervous system, with seizures believed to originate from or involve frontal and parietal cortical networks engaged during cognitive tasks. Seizures are most commonly generalized, often presenting

At what age does Thinking epilepsy typically begin?

Typical onset of Thinking epilepsy is juvenile. Age of onset can vary across affected individuals.

Which specialists treat Thinking epilepsy?

2 specialists and care centers treating Thinking epilepsy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.